The abundant proteins in human milk have been well characterized and are known to provide nutritional, protective, and developmental advantages to both term and preterm infants. However, relatively little is known about the expression of the low abundance proteins that are present in human milk because of the technical difficulties associated with their detection. We used a combination of electrophoretic techniques, ProteoMiner treatment, and two-dimensional liquid chromatography to examine the proteome of human skim milk expressed between 7 and 28 days postpartum by healthy term mothers and identified 415 in a pooled milk sample. Of these, 261 were found in human skim milk for the first time, greatly expanding our understanding of the human skim milk proteome. The majority of the proteins identified were involved in either the immune response (24%) or in cellular (28%) or protein (16%) metabolism. We also used iTRAQ analysis to examine the effects of premature delivery on milk protein composition. Differences in protein expression between pooled milk from mothers delivering at term (38-41 weeks gestation) and preterm (28-32 weeks gestation) were investigated, with 55 proteins found to be differentially expressed with at least 90% confidence. Twenty-eight proteins were present at higher levels in preterm milk, and 27 were present at higher levels in term milk.
A mid-infrared human milk analyzer (HMA) is designed to measure the macronutrients in human milk over a wide range of concentrations. Human milk samples (N = 30, 4 different dilutions each) were used to compare the macronutrient levels determined by the HMA to those derived from traditional laboratory methods. There was a small but statistically significant difference in the levels of fat, protein, lactose, total solids, and energy for all samples. These differences were consistent with subtle differences in the chemical principles governing the assays. For higher macronutrient levels, a trend to greater differences between the HMA and the laboratory method was seen, particularly in samples with high fat concentration. The intra-assay variation for the HMA for all macronutrients was less than 4%. It is concluded that that with appropriate sample preparation, the mid-infrared HMA can provide a practical measurement of macronutrients in human milk.
This paper describes the application of a photoinitiated polymerisation-induced phase separation method to the preparation of PHEMA and P[HEMA-co-(MeO-PEGMA)] hydrogels. PHEMA sponges having a morphology of agglomerated polymer droplets and interconnected pores were easily prepared from aqueous mixtures containing HEMA, EDGMA (crosslinker) and DPAP (photoinitiator). P[HEMA-co-(MeO-PEGMA)] copolymers having similar morphologies could also be prepared, provided that the proportion of MeO-PEGMA in the copolymer was relatively small. When higher proportions of MeO-PEGMA were used, the resulting polymers were gels rather than sponges, and did not show the sought after droplet/pore morphology. P[HEMA-co-(MeO-PEGMA)] copolymers having higher proportions of MeO-PEGMA and having a morphology of agglomerated polymer droplets and interconnected pores were easily prepared by addition of NaCl to the polymerisation mixture. Thus, incorporation of MeO-PEGMA and adddition of NaCl to the photopolymerisation mixtures provides an easy way of tuning the hydrophilicity of PHEMA copolymer sponges without compromising the desired porous morphology.
PHEMA-peptide and P[HEMA-co-(MeO-PEGMA)]-peptide conjugate hydrogels [where PHEMA = poly(2-hydroxyethyl methacrylate; PEGMA = poly(ethylene glycol) methacrylate] were readily prepared via photoinitiated free-radical polymerization in water. The PHEMA-peptide hydrogels were opaque and had a heterogeneous morphology of interconnected polymer droplets, characteristic of polymers that separate from the aqueous phase during the polymerization experiment. The P[HEMA-co-(MeO-PEGMA)]-peptide conjugates were transparent gels with a homogeneous morphology when formed in water, but when formed in aqueous NaCl solutions the P[HEMA-co-(MeO-PEGMA)]-peptide conjugates were also opaque and exhibited the heterogeneous morphology of interconnected polymer droplets. When incubated in solutions containing activated papain, P[HEMA-co-(MeO-PEGMA)]-peptide conjugates underwent degradation that was characterized by macroscopic changes to sample shape and size, sample weight, and microscopic structure. PHEMA-peptide conjugates did not undergo any significant degradation when incubated with papain, although ninhydrin-staining experiments suggested that some peptide cross-linker groups were cleaved during the incubation. The difference in degradation behavior of PHEMA-peptide and P[HEMA-co-(MeO-PEGMA)]-peptide conjugates is attributed to differences in aqueous solubility of PHEMA and P[HEMA-co-(MeO-PEGMA)].
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.